N-(Propargyl)diazenecarboxamides for 'click' conjugation and their 1,3-dipolar cycloadditions with azidoalkylamines in the presence of Cu(II)

Tetrahedron

Volumn 66, Issue 14, 2010, Pages 2602-2613

  Urankar, Damijana ^a   Steinbücher, Miha ^a   Kosjek, Jaka ^a   Košmrlj, Janez ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

1,2,3 Triazoles; Click chemistry; Diazenes; Mechanism

Indexed keywords

1 AZIDO 2 AMINOETHANE; 1 AZIDO 3 AMINOPROPANE; 1 AZIDO 4 AMINOBUTANE; 1,2,3 TRIAZOLE DERIVATIVE; 2 (AZIDOMETHYL)PYRIDINE; 5 AZIDO 1 AMINOPENTANE; ALIPHATIC AMINE; ALKANE DERIVATIVE; ALKYNE DERIVATIVE; AZIDE; COPPER COMPLEX; COPPER SULFATE; N (PROPARGYL)DIAZENECARBOXAMIDE DERIVATIVE; REDUCING AGENT; SEMICARBAZIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; COMPLEX FORMATION; CYCLOADDITION; DRUG CONJUGATION; DRUG STRUCTURE; PRIORITY JOURNAL; REACTION ANALYSIS; SOLUBILITY;

EID: 77649178589     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.02.042     Document Type: Article

References (89)

1. Košmrlj J., Kočevar M., and Polanc S. J. Chem. Soc., Perkin Trans. 1 (1998) 3917-3919
2. Košmrlj J., Kočevar M., and Polanc S. Synlett (2009) 2217-2235
3. Osmak M., Bordukalo T., Košmrlj J., Kvajo M., Marijanović Z., Eljuga D., and Polanc S. Neoplasma 46 (1999) 201-206
4. Osmak M., Bordukalo T., Branimir J., Košmrlj J., and Polanc S. Anti-Cancer Drugs 10 (1999) 853-859
5. Osmak M., Bordukalo T., Ristov Ambriović A., Jernej B., Košmrlj J., and Polanc S. Neoplasma 47 (2000) 390-395
6. Pieters L., Košmrlj J., Lenaršič R., Kočevar M., and Polanc S. Arkivoc V (2001) 42-50
7. Moskatelo D., Benjak A., Lakota V., Polanc S., Košmrlj J., and Osmak M. Chemotherapy 48 (2002) 36-41
8. Moskatelo D., Polanc S., Košmrlj J., Vuković L., and Osmak M. Pharmacol. Toxicol. 91 (2002) 258-263
9. Čimbora T., Bombek S., Polanc S., and Osmak M. Toxicol. in Vitro 17 (2003) 159-164
10. Čimbora-Zovko T., Bombek S., Košmrlj J., Kovačič L., Polanc S., Katalinić A., and Osmak M. Drug Dev. Res. 61 (2004) 95-100
11. Polanc S. J. Heterocycl. Chem. 42 (2005) 401-412
12. Jakopec S., Dubravčić K., Polanc S., Košmrlj J., and Osmak M. Toxicol. in Vitro 20 (2006) 217-226
13. Jakopec S., Dubravčić K., Brozović A., Polanc S., and Osmak M. Cell Biol. Toxicol. 22 (2006) 61-71
14. Martin-Kleiner I., Bombek S., Košmrlj J., Čupić B., Čimbora-Zovko T., Jakopec S., Polanc S., Osmak M., and Gabrilovac J. Toxicol. in Vitro 21 (2007) 1453-1459
15. Grabner S., Košmrlj J., Bukovec N., and Čemažar M. J. Inorg. Biochem. 95 (2003) 105-112
16. Urankar D., and Košmrlj J. J. Comb. Chem. 10 (2008) 981-985
17. Tornøe C.W., Christensen C., and Meldal M. J. Org. Chem. 67 (2002) 3057-3064
18. Rostovtsev V.V., Green L.G., Fokin V.V., and Sharpless K.B. Angew. Chem., Int. Ed. 41 (2002) 2596-2599
19. For selected reviews on CuAAC, see:
20. Kolb H.C., Finn M.G., and Sharpless K.B. Angew. Chem., Int. Ed. 40 (2001) 2004-2021
21. Kolb H.C., and Sharpless K.B. Drug Discov. Today 8 (2003) 1128-1137
22. Bock V.D., Hiemstra H., and van Maarseveen J.H. Eur. J. Org. Chem. (2006) 51-68
23. Moses J.E., and Moorhouse A.D. Chem. Soc. Rev. 36 (2007) 1249-1262
24. Lutz J.F. Angew. Chem., Int. Ed. 46 (2007) 1018-1025
25. Fournier D., Hoogenboom R., and Schubert U.S. Chem. Soc. Rev. 36 (2007) 1369-1380
26. Binder W.H., and Sachsenhofer R. Macromol. Rapid Commun. 28 (2007) 15-54
27. Peng W., and Fokin V.V. Aldrichimica Acta 40 (2007) 7-17
28. Tron G.C., Pirali T., Billington R.A., Canonico P.L., Sorba G., and Genazzani A.A. Med. Res. Rev. 28 (2008) 278-308
29. Lutz J.-F., and Zarafshani Z. Adv. Drug Delivery Rev. 60 (2008) 958-970
30. Meldal M., and Tornøe C.W. Chem. Rev. 108 (2008) 2952-3015
31. Hein C.D., Liu X.-M., and Wang D. Pharm. Res. 25 (2008) 2216-2230
32. Lutz J.-F. Angew. Chem., Int. Ed. 47 (2008) 2182-2184
33. Le Droumaguet B., and Velonia K. Macromol. Rapid Commun. 29 (2008) 1073-1089
34. Meldal M. Macromol. Rapid Commun. 29 (2008) 1016-1051
35. Mamat C., Ramenda T., and Wuest F.R. Mini-Rev. Org. Chem. 6 (2009) 21-34
36. For an informative reading, see:
37. Prescher J.A., and Bertozzi C.R. Nat. Chem. Biol. 1 (2005) 13-21
38. van Swieten P.F., Leeuwenburgh M.A., Kessler B.M., and Overkleeft H.S. Org. Biomol. Chem. 3 (2005) 20-27
39. Inverarity I.A., and Hulme A.N. Org. Biomol. Chem. 5 (2007) 636-643
40. Selected reviews on isocyanates:
41. Ozaki S. Chem. Rev. 72 (1972) 457-496
42. Caraculacu A.A., and Coseri S. Prog. Polym. Sci. 26 (2001) 799-851
43. Košmrlj J., Kočevar M., and Polanc S. Synlett (1996) 652-654
44. For selected recent reviews on triphosgene, see:
45. Cotarca L., Delogu P., Nardelli A., and Šunjić V. Synthesis (1996) 553-576
46. Pasquato L., Modena G., Cotarca L., Delogu P., and Mantovani S. J. Org. Chem. 65 (2000) 8224-8228
47. Shachat N., and Bangell Jr. J.J. J. Org. Chem. 28 (1963) 991-995
48. Štefane B., and Polanc S. Synlett (2008) 1279-1282
49. Kauer J.C. Org. Synth. Coll. 4 (1963) 411-415
50. Tschirret-Guth R.A., and Oritz de Montellano P.R. J. Org. Chem. 63 (1998) 9711-9715
51. Bock H. Angew. Chem. 77 (1965) 469-484
52. Chan T.R., Hilgraf R., Sharpless K.B., and Fokin V.V. Org. Lett. 6 (2004) 2853-2855
53. Donnelly P.S., Zanatta S.D., Zammit S.C., White J.M., and Williams S.J. Chem. Commun. (2008) 2459-2461
54. II, see:. Matyjaszewski K., Tsarevsky N.V., Braunecker W.A., Dong H., Huang J., Jakubowski W., Kwak Y., Nicolay R., Tang W., and Yoon J.A. Macromolecules 40 (2007) 7795-7806
55. Reddy K.R., Rajgoppal K., and Kantam M.L. Synlett (2006) 957-959
56. Bonnamour J., Legros J., Crousse B., and Bonnet-Delpon D. Tetrahedron Lett. 48 (2007) 8360-8362
57. Reddy K.R., Rajgopal K., and Kantam M.L. Catal. Lett. 114 (2007) 36-40
58. Fukuzawa S.-I., Shimizu E., and Kikuchi S. Synlett (2007) 2436-2438
59. Song Y.-J., Yoo C., Hong J.-T., Kim S.-J., Son S.U., and Jang H.-Y. Bull. Korean Chem. Soc. 29 (2008) 1561-1564
60. Namitharan K., Kumaaraja M., and Pitchumani K. Chem.-Eur. J. 15 (2009) 2755-2758
61. Strieter E.R., Bhayana B., and Buchwald S.L. J. Am. Chem. Soc. 131 (2009) 78-88 and references therein
62. Brotherton W.S., Michaels H.A., Simmons J.T., Clark R.J., Dalal N.S., and Zhu L. Org. Lett. 11 (2009) 4954-4957
63. Rodionov V.O., Presolski S.I., Gardinier S., Lim Y.-H., and Finn M.G. J. Am. Chem. Soc. 129 (2007) 12696-12704
64. Golas P.L., Tsarevsky N.V., Sumerlin B.S., and Matyjaszewski K. Macromolecules 39 (2006) 6451-6457
65. Urbani C.N., Bell C.A., Whittaker M.R., and Monteiro M.J. Macromolecules 41 (2008) 1057-1060
66. Mindt T.L., Struthers H., Brans L., Anguelov T., Schweinsberg C., Maes V., Tourwé D., and Schibli R. J. Am. Chem. Soc. 128 (2006) 15096-15097
67. Maisonial A., Serafin P., Traïkia M., Debiton E., Théry V., Aitken D.J., Lemoine P., Viossat B., and Gautier A. Eur. J. Inorg. Chem. (2008) 298-305
68. II complex with 1-azido-2-pyrazolyl-cyclohexane featuring similar connectivity as proposed for intermediate C in Scheme 10: {A figure is presented}
69. see:. Barz M., Herdtweck E., and Thiel W.R. Angew. Chem., Int. Ed. 37 (1998) 2262-2265
70. For a review on coordination chemistry of organic azides, see:. Cenini S., Gallo E., Caselli A., Ragaini F., Fantauzzi S., and Piangiolino C. Coord. Chem. Rev. 250 (2006) 1234-1253
71. Ossipov D.A., and Hilborn J. Macromolecules 39 (2006) 1709-1718
72. Wu J., Green N., Hotchandani R., Hu Y., Condon J., Huang A., Kaila N., Li H.-Q., Guler S., Li W., Tam S.Y., Wang Q., Pelker J., Marusic S., Hsu S., Hall J.P., Telliez J.-B., Cui J., and Lin L.-L. Bioorg. Med. Chem. Lett. 19 (2009) 3485-3488
73. Zhou L., Amer A., Korn M., Burda R., Balzarini J., De Clercq E., Kern E.R., and Torrence P.F. Antiviral Chem. Chemother. 16 (2005) 375-383
74. Martin A.L., Bernas L.M., Rutt B.K., Foster P.J., and Gillies E.R. Bioconjugate Chem. 19 (2008) 2375-2384
75. Mazitschek R., Patel V., Wirth D.F., and Clardy J. Bioorg. Med. Chem. Lett. 18 (2008) 2809-2812
76. Tamanini E., Rigby S.E.J., Motevalli M., Todd M.H., and Watkinson M. Chem.-Eur. J. 15 (2009) 3720-3728
77. Kinetic studies with diazenes 1 as substrates using GC, HPLC or UV-vis spectrometry are hampered because of their specific solubility and UV-vis features.
78. Azides can be explosive and caution should be exercised when handling them.
79. For a review on synthesis and reactivity of azides, see:. Bräse S., Gil C., Knepper K., and Zimmermann V. Angew. Chem., Int. Ed. 44 (2005) 5188-5240
80. Spencer L.P., Altwer R., Wei P., Gelmini L., Gauld J., and Stephan D.W. Organometallics 22 (2003) 3841-3854
81. Benalil A., Carboni B., and Vaultier M. Tetrahedron 47 (1991) 8177-8194
82. Lee J.W., Jun S.I., and Kim K. Tetrahedron Lett. 42 (2001) 2709-2711
83. Carboni B., Benalil A., and Vaultier M. J. Org. Chem. 58 (1993) 3736-3741
84. Srinivasan V., Jebaratnam D.J., and Budil D.E. J. Org. Chem. 64 (1999) 5644-5649
85. Werndl, A. Ger. Patent, DE 2246282, 1973;
86. Chem. Abstr. 78 (1973) 159286e
87. Pilgram K.H. Synth. Commun. 15 (1985) 697-706
88. Lenaršič R., Kočevar M., and Polanc S. J. Org. Chem. 64 (1999) 2558-2563
89. Eckell A., and Huisgen R. Chem. Ber. 110 (1977) 559-570